13F

Stock

Enanta Pharmaceuticals Inc

ENTA · held by 8 managers

Reported value

$29.8M

Holders

8

+1 new · −1 exited

Holders’ est. mark

$190.2K

Price effect on 2 books still in the name

Largest holder

$25.4M

FARALLON CAPITAL MANAGEMENT LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
FARALLON CAPITAL MANAGEMENT LLC2.12M$25.4MNew
MORGAN STANLEY282.6K$3.38MHeld
BARCLAYS PLC41.6K$498.2K$183.5KAdded$136.2K
BANK OF AMERICA CORP /DE/30K$358.5KHeld
TUDOR INVESTMENT CORP ET AL10.4K$125KHeld
Essential Partners LLC1.52K$18.1K$6.69KAdded$6.25K
IFP Advisors, Inc396$4.74KHeld
Allworth Financial LP233$2.79KHeld

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.